Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Oragenics (OGEN)

Oragenics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:OGEN
DateTimeSourceHeadlineSymbolCompany
20/09/202421:11Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
11/09/202412:45Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:OGENOragenics Inc
05/09/202421:45Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
05/09/202421:30GlobeNewswire Inc.Oragenics, Inc. Announces Closing of Public OfferingAMEX:OGENOragenics Inc
05/09/202413:26Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:OGENOragenics Inc
04/09/202413:36GlobeNewswire Inc.Oragenics, Inc. Announces Pricing of Public OfferingAMEX:OGENOragenics Inc
04/09/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:OGENOragenics Inc
03/09/202421:06Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:OGENOragenics Inc
21/08/202413:45GlobeNewswire Inc.Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed PatientsAMEX:OGENOragenics Inc
21/08/202413:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
16/08/202421:45Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:OGENOragenics Inc
16/08/202421:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
16/08/202421:30GlobeNewswire Inc.Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing StandardsAMEX:OGENOragenics Inc
14/08/202413:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
14/08/202413:30GlobeNewswire Inc.Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature RangeAMEX:OGENOragenics Inc
12/08/202413:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
12/08/202413:30GlobeNewswire Inc.Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity StudyAMEX:OGENOragenics Inc
09/08/202421:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:OGENOragenics Inc
08/08/202413:45GlobeNewswire Inc.Oragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity TestingAMEX:OGENOragenics Inc
08/08/202413:30Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
22/07/202421:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
10/07/202413:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
10/07/202413:00GlobeNewswire Inc.Oragenics Improves Intranasal Drug Formulation for Treating Concussed PatientsAMEX:OGENOragenics Inc
27/06/202413:30GlobeNewswire Inc.Oragenics Develops Automated Intranasal Device for Treating Concussed PatientsAMEX:OGENOragenics Inc
26/06/202421:47GlobeNewswire Inc.Oragenics, Inc. Announces Closing of Public OfferingAMEX:OGENOragenics Inc
25/06/202413:30GlobeNewswire Inc.Oragenics, Inc. Announces Pricing of Public OfferingAMEX:OGENOragenics Inc
24/06/202423:43GlobeNewswire Inc.Oragenics, Inc. Announces Proposed Public OfferingAMEX:OGENOragenics Inc
20/06/202413:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
20/06/202413:00GlobeNewswire Inc.Oragenics, Inc. Announces NYSE American Acceptance of Plan of ComplianceAMEX:OGENOragenics Inc
23/05/202414:27Edgar (US Regulatory)Form 8-K - Current reportAMEX:OGENOragenics Inc
 Showing the most relevant articles for your search:AMEX:OGEN